Medtronic to participate in investor conferences in September.
ByAinvest
Friday, Aug 29, 2025 11:32 am ET1min read
MDT--
Conference Details:
- 2025 Wells Fargo Healthcare Conference:
- Date: Thursday, September 4, 2025
- Time: 8:00 a.m. EDT (7:00 a.m. CDT)
- Speakers: Geoff Martha, chairman and CEO, and Thierry Piéton, executive vice president and chief financial officer
- Morgan Stanley 23rd Annual Global Healthcare Conference:
- Date: Monday, September 8, 2025
- Time: 4:50 p.m. EDT (3:50 p.m. CDT)
- Speaker: Thierry Piéton, executive vice president and chief financial officer
- 2025 Deutsche Bank Healthcare Summit:
- Date: Wednesday, September 10, 2025
- Time: 12:00 p.m. EDT (11:00 a.m. CDT)
- Speaker: Greg Smith, executive vice president, enterprise operations
- BofA Global Research Global Healthcare Conference 2025:
- Date: Wednesday, September 24, 2025
- Time: 2:10 p.m. BST (8:10 a.m. CDT)
- Speaker: Thierry Piéton, executive vice president and chief financial officer
Live Webcast and Archive Availability:
A live webcast for each session will be available on the date and time of each conference. An archive session will be available on the same webpage later in the day. Interested investors can access these sessions by clicking on the "Investors Events" link at: [http://investorrelations.medtronic.com](http://investorrelations.medtronic.com).
About Medtronic:
Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company. The company's mission is to alleviate pain, restore health, and extend life. It employs over 95,000 people across more than 150 countries and delivers innovative technologies that treat 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems [1].
References:
[1] https://finance.yahoo.com/news/medtronic-executives-speak-upcoming-investor-152100455.html
Medtronic plc, a global leader in healthcare technology, announced its participation in several investor conferences in September 2025. Geoff Martha, CEO, and Thierry Piéton, CFO, will speak at the 2025 Wells Fargo Healthcare Conference and Morgan Stanley 23rd Annual Global Healthcare Conference. Thierry Piéton will also speak at the 2025 Deutsche Bank Healthcare Summit, and Greg Smith will speak at the BofA Global Research Global Healthcare Conference 2025.
Medtronic plc, a global leader in healthcare technology, has announced its participation in several investor conferences in September 2025. The company will be represented by key executives at the 2025 Wells Fargo Healthcare Conference, Morgan Stanley 23rd Annual Global Healthcare Conference, 2025 Deutsche Bank Healthcare Summit, and BofA Global Research Global Healthcare Conference 2025.Conference Details:
- 2025 Wells Fargo Healthcare Conference:
- Date: Thursday, September 4, 2025
- Time: 8:00 a.m. EDT (7:00 a.m. CDT)
- Speakers: Geoff Martha, chairman and CEO, and Thierry Piéton, executive vice president and chief financial officer
- Morgan Stanley 23rd Annual Global Healthcare Conference:
- Date: Monday, September 8, 2025
- Time: 4:50 p.m. EDT (3:50 p.m. CDT)
- Speaker: Thierry Piéton, executive vice president and chief financial officer
- 2025 Deutsche Bank Healthcare Summit:
- Date: Wednesday, September 10, 2025
- Time: 12:00 p.m. EDT (11:00 a.m. CDT)
- Speaker: Greg Smith, executive vice president, enterprise operations
- BofA Global Research Global Healthcare Conference 2025:
- Date: Wednesday, September 24, 2025
- Time: 2:10 p.m. BST (8:10 a.m. CDT)
- Speaker: Thierry Piéton, executive vice president and chief financial officer
Live Webcast and Archive Availability:
A live webcast for each session will be available on the date and time of each conference. An archive session will be available on the same webpage later in the day. Interested investors can access these sessions by clicking on the "Investors Events" link at: [http://investorrelations.medtronic.com](http://investorrelations.medtronic.com).
About Medtronic:
Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company. The company's mission is to alleviate pain, restore health, and extend life. It employs over 95,000 people across more than 150 countries and delivers innovative technologies that treat 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems [1].
References:
[1] https://finance.yahoo.com/news/medtronic-executives-speak-upcoming-investor-152100455.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet